Seeking Druggable Targets and Technologies to Monitor Glomerular Filtration Rate in Chronic Kidney Disease and Acute Kidney Injury January 15, 2021 News, Requests for proposals Johnson & Johnson, a global pharmaceutical company with cutting-edge capabilities in drug development and a history of successful academic collaborations wishes to identify druggable targets in Chronic Kidney Disease and Acute Kidney Injury.
Comments are closed.